FFP
BSX icon

FourThought Financial Partners’s Boston Scientific BSX Stock Holding History

FourThought Financial Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$493K Buy
11,542
+45
+0.4% +$2.44K 0.04% 206
2026
Q1 		$721K Buy
11,497
+53
+0.5% +$4.24K 0.06% 157
2025
Q4 		$1.09M Sell
11,444
-328
-3% -$32.2K 0.09% 134
2025
Q3 		$1.15M Buy
11,772
+136
+1% +$14.1K 0.1% 128
2025
Q2 		$1.25M Buy
11,636
+15
+0.1% +$1.52K 0.12% 120
2025
Q1 		$1.17M Buy
11,621
+8,672
+294% +$873K 0.12% 120
2024
Q4 		$263K Buy
+2,949
New +$260K 0.03% 262
2023
Q3 		– Sell
-4,381
Closed -$237K – 314
2023
Q2 		$237K Sell
4,381
-1,125
-20% -$58.8K 0.03% 291
2023
Q1 		$275K Sell
5,506
-725
-12% -$34.2K 0.04% 261
2022
Q4 		$288K Buy
+6,231
New +$270K 0.04% 253

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FourThought Financial Partners's BSX Position: Q2 2026 in Review

FourThought Financial Partners increased its Boston Scientific (BSX) stake by 0.39% in Q2 2026, buying an estimated $2.44K and bringing the position to 11,542 shares worth $493K. The position accounts for 0.04% of the portfolio, ranked #206.

FourThought Financial Partners first reported a position in BSX in Q4 2022 and has held it in 10 quarters since. The position peaked at $1.25M in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • FourThought Financial Partners held 11,542 shares of Boston Scientific worth $493K as of Q2 2026.
  • FourThought Financial Partners bought 45 Boston Scientific shares in Q2 2026, an estimated $2.44K.
  • Boston Scientific made up 0.04% of FourThought Financial Partners's portfolio in Q2 2026, its #206 holding.
  • FourThought Financial Partners first reported a position in Boston Scientific in Q4 2022 and has held it in 10 quarters since.
  • FourThought Financial Partners's Boston Scientific position peaked at $1.25M in Q2 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on FourThought Financial Partners's 13F filing for Q2 2026, filed 12 Aug 2026.